scholarly article | Q13442814 |
P2093 | author name string | James S Louie | |
Seth R Stevens | |||
Tadahiko Kohno | |||
Lei-Ting T Tam | |||
P2860 | cites work | Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial | Q28296771 |
Switching TNF antagonists in patients with chronic arthritis: an observational study of 488 patients over a four-year period | Q34896269 | ||
Differentiating the efficacy of the tumor necrosis factor inhibitors | Q36106349 | ||
Clinical pharmacokinetics of TNF antagonists: how do they differ? | Q36106353 | ||
The role of non-immune IgG in controlling IgG-mediated effector functions | Q40116339 | ||
Caspase activation and apoptosis induction by adalimumab: demonstration in vitro and in vivo in a chimeric mouse model | Q40336783 | ||
Infliximab induces apoptosis of monocytes and T lymphocytes in a human-mouse chimeric model | Q40422633 | ||
Chimeric anti-TNF-α monoclonal antibody cA2 binds recombinant transmembrane TNF-α and activates immune effector functions | Q41355139 | ||
Granulomatous infectious diseases associated with tumor necrosis factor antagonists | Q47648712 | ||
A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. | Q53964227 | ||
Binding and Functional Comparisons of Two Types of Tumor Necrosis Factor Antagonists | Q56864876 | ||
Granulomatous infections due to tumor necrosis factor blockade: correction | Q80867344 | ||
Adalimumab induces apoptosis of human monocytes: a comparative study with infliximab and etanercept | Q81361610 | ||
Reactivation of latent granulomatous infections by infliximab | Q81898771 | ||
P433 | issue | 1 | |
P304 | page(s) | 5-8 | |
P577 | publication date | 2007-05-01 | |
P1433 | published in | The journal of investigative dermatology. Symposium proceedings | Q26842290 |
P1476 | title | Binding characteristics of tumor necrosis factor receptor-Fc fusion proteins vs anti-tumor necrosis factor mAbs | |
P478 | volume | 12 |